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Supplemental Figure legends
Figure S1, Gel filtration chromatography showed the existence of DDA3 and EB1 at the same fractions. HeLa cell extracts were separated using a Superose 6 10/300 GL column (GE Healthcare) followed by Western blotting analysis with anti-DDA3 and anti-EB1
antibodies. Numbers indicate fractions. Supplemental Tables   Table S1, 
Supplemental Movies
Movie S1, DDA3 tracks MT plus ends in living cell.
HeLa was transfected with GFP-DDA3 for 24 hr. Images were collected every 5 s and are
shown at a speed of 15 frames per second (fps). Representative frame is shown in Figure   2b Movie S2, DDA3 tracks MT growing plus ends in the presence of EB1 in vitro.
TIRF imaging of MT plus-end tracking of GFP-DDA3 122-363 in the presence of EB1 in an in vitro reconstituted system. Images were collected every 2 s and are shown at a speed of 15 fps.
Movie S3, DDA3 is required for MT plus-end stabilization at cell cortex.
MT plus-ends dynamics (mCherry-α-tubulin labeled) at cell cortex in DDA3-depletion or control cells. Images were collected every 2 s and are shown at a speed of 15 fps.
Representative frames are shown in Figure 4a . 
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Plasmid construction
The full-length cDNA of human DDA3 was kindly provided by Dr. Guowei Fang (GeneTech, South San Francisco, CA, USA). To generate GFP-tagged DDA3, PCR-amplified cDNA was cloned into pEGFP-C2 vector (Clontech, Mountain View, CA, USA) with EcoRI and SalI digestion. Then DDA3 was then subcloned into the following vectors: p3×FLAG (Sigma, Saint Louis, USA), pET-28a (Novagen, WI, USA) and pGEX-6P (Amersham Biosciences, USA). Point mutations in DDA3 were generated using the Site-Directed Mutagenesis kit (Agilent Technologies, CA USA). All DDA3 deletion mutants were created by PCR and confirmed by DNA sequencing. EB1 constructions were described previously 48 .
Recombinant protein expression
His-DDA3, GST-DDA3, GST-EB1 and mutants were all expressed in Rosetta (DE3) pLysS (Novagen). Briefly, the protein expression was induced by addition of 0.5 mM IPTG at 16℃ for 14-20 hours. Bacterial cells were then collected and the proteins were purified using Ni-NTA resin or glutathione-agarose, respectively, as described previously 49 .
Immunoprecipitation
Immunoprecipitations were performed as described previously 49 . Briefly, 293T cells were grown to ~50% confluency in DMEM and were then co-transfected with FLAG-DDA3 and EB1-GFP or GFP using Ca 3 (PO4) 2 methods. Cells were then harvested 36h after transfection. Cell lysates were prepared by sonication on ice in lysis buffer (50 mM HEPES PH 7.4, 100 mM NaCl, 2 mM EGTA, 1 mM MgCl 2 . 1mM DTT) containing 0.25%
Triton X-100, 1 mM PMSF and protease inhibitor cocktail (Sigma). The lysates were centrifugated and then incubated with agarose beads coupled with anti-FLAG (M2) antibody (Sigma). The beads were washed three times with the lysis buffer containing 0.25% Triton X-100 and 1mM PMSF, and then once with the lysis buffer alone. Beads were then boiled and analyzed using Western blotting with anti-FLAG and anti-GFP antibodies, respectively.
Gel filtration
HeLa cell lysates were prepared by sonication in lysis buffer (50 mM PIPES-K, pH 6.9, 1 mM EGTA, 5 mM MgCl2, and 50mM NaCl) plus protease inhibitor cocktail (Sigma). After centrifugation, the supernatant was loaded into a pre-equilibrated Superose 6 10/300
GL column (GE Healthcare) set up on a fast protein liquid chromatograph. Elution was carried out at a flow rate of 0.5 ml/min. Equal amounts of chromatographic fractions were then separated by SDS-PAGE followed by Western blotting analysis with indicated antibodies. 
